ENLVNasdaq

Enlivex Ltd.

Pharmaceutical Preparations · L3 · CIK 1596812

Enlivex Ltd. advances therapies to extend health span and improve quality of life, combining clinical development with a prediction markets treasury

+ Watch View on EDGAR ↗

$127M

Market cap

$6.86

Last close

-7.3%

+1200.2%

97K

Volume

Price$6.86+411.9%· 1Y

Volume

Jul 10L $0.49 · H $7.40Jul 10

Fundamentals & quality

Fundamentals not yet available for this company.

Similar companies

Comparable business profile · signals at a glance

CNTNCanton Strategic Holdings, Inc.$219.0M+3.9%HSDTSolana Co🔥$104.5M-4.4%SBETSharplink, Inc.$1.1B+3.6%AGPUAxe Compute Inc.$76.6M+5.6%BMNRBITMINE IMMERSION TECHNOLOGIES, INC.

Filings archive

Newest first · each with a one-line AI read · showing 10 of 304

Jun 24, 20266-KREPORT OF FOREIGN PRIVATE ISSUEREnlivex Ltd. announced that its RAIN token is expected to be listed on the Gate cryptocurrency exchange on June 24, 2026. This listing is considered the company's primary treasury asset.Jun 22, 20266-KREPORT OF FOREIGN PRIVATE ISSUEREnlivex Ltd. issued a press release on June 22, 2026, providing an update on its RAIN token holdings.May 28, 20266-KREPORT OF FOREIGN PRIVATE ISSUEREnlivex Ltd. issued a press release on May 28, 2026, providing an update on its RAIN token holdings. (2) * The reporting currency is not stated.

REPORT OF FOREIGN PRIVATE ISSUEREnlivex Ltd. issued a press release commenting on the Rain Foundation’s announcement of a $100 million liquidity commitment to Rain’s prediction markets protocol.